S
NUTX

SignatureFD’s Nutex Health NUTX Stock Holding History

SignatureFD’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$494 – 3558
2025
Q4 		$494 Buy
+3
New +$398 ﹤0.01% 3235

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

SignatureFD's NUTX Position: Q1 2026 in Review

SignatureFD sold out of Nutex Health (NUTX) in Q1 2026, closing a stake of 3 shares — an estimated $494 sold.

SignatureFD first reported a position in NUTX in Q4 2025 and held it in 1 quarter. The position peaked at $494 in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • SignatureFD reported no remaining Nutex Health position as of Q1 2026 after selling out during the quarter.
  • SignatureFD sold 3 Nutex Health shares in Q1 2026, an estimated $494.
  • SignatureFD first reported a position in Nutex Health in Q4 2025 and held it in 1 quarter.
  • SignatureFD's Nutex Health position peaked at $494 in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.